Evolus, Inc.
NASDAQ:EOLS · NASDAQ Global Market
-$0.14 today
Vol 1.06M · Avg 0.86M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-29.32%
Period High
$9.73
Period Low
$3.94
Latest
$6.63
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Enhabit, Inc.
EHAB
$706.91M
CeriBell, Inc.
NASDAQ:CBLL
$669.12M
Solid Biosciences Inc.
NASDAQ:SLDB
$591.03M
The Oncology Institute, Inc.
NASDAQ:TOI
$519.41M
Neurogene Inc.
NASDAQ:NGNE
$498.63M
OrthoPediatrics Corp.
NASDAQ:KIDS
$471.32M
Kamada Ltd.
NASDAQ:KMDA
$420.53M
Autolus Therapeutics plc
NASDAQ:AUTL
$407.20M
Treace Medical Concepts, Inc.
NASDAQ:TMCI
$265.01M
Quantum-Si incorporated
NASDAQ:QSI
$193.02M
What is the latest EOLS filing?
The latest filing shown is 8-K dated Jun 12, 2026.
How many recent filings does EOLS have?
Intrinsic Alpha currently shows 20 recent filings for EOLS.
Explore More
Continue the stock analysis
Jump to another research area for this company.